Latest news
Loading news…
Ermium Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Paris, Ile-de-France, France Founded 2019 1-10 employees For Profit
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 12
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $140K
Company Info
- Founded
- 2019
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 1
- HQ
- Paris, Ile-de-France, France
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 1.5
- Trend (30d)
- 1.5
- Trend (90d)
- 2.1
Key People at Ermium Therapeutics
Scientific Founder
Head Medicinal Chemistry
Chief Executive Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ermium Therapeutics
Loading news…
FAQs about Ermium Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.